RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI)

RAvulizumab to PRotect PaTients with Chronic Kidney DisEase (CKD) froM Cardiac Surgery Associated Acute Kidney Injury (CSA-AKI) and Subsequent Major Adverse Kidney Events (MAKE): A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study

Abierta

Código protocolo: ALXN1210-CSA-AKI-318
Código EudraCT: No aplica
Grupo de investigación: Shock, Disfunción Orgánica y Resucitación
Servicio: UCI ATR
Investigador/a principal: Ferrer Roca, Ricard
Patología: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Fase: Fase III